SUVEN PHARMACEUTICALS
Back to Income Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit After Tax | ₹411 Cr | ₹454 Cr | ₹362 Cr | ₹317 Cr | ₹109 Cr |
What is the latest Profit After Tax of SUVEN PHARMACEUTICALS ?
Year | Profit After Tax |
---|---|
Mar2024 | ₹411 Cr |
Mar2023 | ₹454 Cr |
Mar2022 | ₹362 Cr |
Mar2021 | ₹317 Cr |
Mar2020 | ₹109 Cr |
How is Profit After Tax of SUVEN PHARMACEUTICALS Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹411 Cr | -9.37 | |
Mar2023 | ₹454 Cr | 25.24 | |
Mar2022 | ₹362 Cr | 14.30 | |
Mar2021 | ₹317 Cr | 190.10 | |
Mar2020 | ₹109 Cr | - |
Compare Profit After Tax of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹26,432.6 Cr | 3.3% | -7.6% | 48.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,744.0 Cr | -4.2% | -7.7% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,209.0 Cr | -0.6% | -5.6% | 57.5% | Stock Analytics | |
CIPLA | ₹117,762.0 Cr | 3.3% | -4.8% | 6.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,705.3 Cr | -2.4% | -12.8% | 1.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,929.3 Cr | -0.3% | -2.1% | 24.5% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 3.3% |
-7.6% |
48.2% |
SENSEX | 0.3% |
-1.8% |
8.6% |
You may also like the below Video Courses